Ftse Mib
34.780,81
1,91%
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
NASDAQ
19.864,98
1,24%
Bitcoin
101.728,03
-0,55%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Prelude Therapeutics Inc (PRLD) Prelude Therapeutics Inc (PRLD) Notizie

Prelude Therapeutics Inc

PRLD
1,27
-0,12 (-8,63%)
07 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/1/202513:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202413:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202413:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202413:45EDGAR2Form 8-K - Current report
11/12/202413:30GLOBEPrelude Therapeutics Presents Preliminary Results of Phase 1..
27/11/202413:30GLOBEPrelude Therapeutics to Participate in Citizens JMP..
06/11/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:05GLOBEPrelude Therapeutics Reports Third Quarter 2024 Financial..
24/10/202413:40EDGAR2Form 8-K - Current report
24/10/202413:30GLOBEPrelude Therapeutics Presents New Data from SMARCA Degrader..
09/10/202413:30GLOBEPrelude Therapeutics Announces Publication of Abstracts for..
13/9/202416:00GLOBEPrelude Therapeutics’ SMARCA2 Degrader PRT3789 Demonstrated..
09/9/202415:02EDGAR2Form 8-K - Current report
09/9/202413:30GLOBEPrelude Therapeutics Announces Publication of Abstract for..
12/8/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202413:10EDGAR2Form 8-K - Current report
12/8/202413:01GLOBEPrelude Therapeutics Reports Second Quarter 2024 Financial..
09/7/202413:30GLOBEPrelude Therapeutics Announces Clinical Collaboration with..
08/7/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:06EDGAR2Form 8-K - Current report
12/6/202412:55EDGAR2Form 8-K - Current report
11/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
03/6/202413:01GLOBEPrelude Therapeutics to Participate in Upcoming Healthcare..
30/5/202422:29EDGAR2Form S-3 - Registration statement under Securities Act of..
16/5/202422:09EDGAR2Form 8-K/A - Current report: [Amend]
16/5/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202413:01GLOBEPrelude Therapeutics to Participate in Citizens JMP Life..
07/5/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:12EDGAR2Form 8-K - Current report
07/5/202413:01GLOBEPrelude Therapeutics Reports First Quarter 2024 Financial..
06/5/202422:24EDGAR2Form S-3/A - Registration statement under Securities Act of..
09/4/202422:35GLOBEPrelude Highlights Continued Strength of Discovery Engine at..
05/3/202422:45GLOBEPrelude Announces Acceptance of Multiple Preclinical..
05/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:05GLOBEPrelude Therapeutics to Participate in Barclays Global..
15/2/202423:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:22EDGAR2Form 8-K - Current report
15/2/202422:05GLOBEPrelude Therapeutics Reports Full Year 2023 Financial..
12/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,385 Min: 1,285 Max: 1,43
Chiusura: 1,39

La tua Cronologia

NASDAQ
PRLD
Prelude Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network